Annual EBITDA
-$12.57 M
-$22.06 M-232.42%
31 December 2023
Summary:
Cytek Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$12.57 million, with the most recent change of -$22.06 million (-232.42%) on 31 December 2023. During the last 3 years, it has fallen by -$27.93 million (-181.80%). CTKB annual EBITDA is now -181.80% below its all-time high of $15.37 million, reached on 31 December 2020.CTKB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$3.08 M
+$7.66 M+167.48%
30 September 2024
Summary:
Cytek Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently $3.08 million, with the most recent change of +$7.66 million (+167.48%) on 30 September 2024. Over the past year, it has increased by +$4.12 million (+399.22%). CTKB quarterly EBITDA is now -63.66% below its all-time high of $8.49 million, reached on 31 December 2020.CTKB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$649.00 K
+$4.12 M+86.38%
30 September 2024
Summary:
Cytek Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$649.00 thousand, with the most recent change of +$4.12 million (+86.38%) on 30 September 2024. Over the past year, it has increased by +$4.02 million (+86.11%). CTKB TTM EBITDA is now -103.22% below its all-time high of $20.16 million, reached on 30 June 2021.CTKB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTKB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -232.4% | +399.2% | +86.1% |
| 3 y3 years | -181.8% | +14.1% | -104.1% |
| 5 y5 years | - | - | - |
CTKB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -181.8% | at low | -55.5% | +147.0% | -104.1% | +86.4% |
| 5 y | 5 years | -181.8% | +21.4% | -63.7% | +147.0% | -103.2% | +86.4% |
| alltime | all time | -181.8% | +21.4% | -63.7% | +147.0% | -103.2% | +86.4% |
Cytek Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.08 M(-167.5%) | -$649.00 K(-86.4%) |
| June 2024 | - | -$4.57 M(-25.0%) | -$4.76 M(+21.1%) |
| Mar 2024 | - | -$6.09 M(-187.9%) | -$3.93 M(-10.8%) |
| Dec 2023 | -$12.57 M(-232.4%) | $6.93 M(-772.2%) | -$4.41 M(-5.7%) |
| Sept 2023 | - | -$1.03 M(-72.4%) | -$4.67 M(+1156.2%) |
| June 2023 | - | -$3.74 M(-43.0%) | -$372.00 K(-108.9%) |
| Mar 2023 | - | -$6.57 M(-198.5%) | $4.17 M(-56.1%) |
| Dec 2022 | $9.49 M | $6.67 M(+103.8%) | $9.49 M(+113.4%) |
| Sept 2022 | - | $3.27 M(+308.8%) | $4.45 M(+14.6%) |
| June 2022 | - | $800.00 K(-164.4%) | $3.88 M(-44.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$1.24 M(-176.7%) | $6.98 M(-21.7%) |
| Dec 2021 | $8.92 M(-41.9%) | $1.62 M(-40.1%) | $8.92 M(-43.5%) |
| Sept 2021 | - | $2.71 M(-30.7%) | $15.79 M(-21.7%) |
| June 2021 | - | $3.90 M(+462.1%) | $20.16 M(+21.3%) |
| Mar 2021 | - | $694.00 K(-91.8%) | $16.62 M(+8.1%) |
| Dec 2020 | $15.37 M(-196.1%) | $8.49 M(+19.9%) | $15.37 M(+123.5%) |
| Sept 2020 | - | $7.08 M(+1899.4%) | $6.88 M(-3504.0%) |
| June 2020 | - | $354.00 K(-163.7%) | -$202.00 K(-63.7%) |
| Mar 2020 | - | -$556.00 K | -$556.00 K |
| Dec 2019 | -$15.98 M | - | - |
FAQ
- What is Cytek Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Cytek Biosciences?
- What is Cytek Biosciences annual EBITDA year-on-year change?
- What is Cytek Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Cytek Biosciences?
- What is Cytek Biosciences quarterly EBITDA year-on-year change?
- What is Cytek Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Cytek Biosciences?
- What is Cytek Biosciences TTM EBITDA year-on-year change?
What is Cytek Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of CTKB is -$12.57 M
What is the all time high annual EBITDA for Cytek Biosciences?
Cytek Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is $15.37 M
What is Cytek Biosciences annual EBITDA year-on-year change?
Over the past year, CTKB annual earnings before interest, taxes, depreciation & amortization has changed by -$22.06 M (-232.42%)
What is Cytek Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of CTKB is $3.08 M
What is the all time high quarterly EBITDA for Cytek Biosciences?
Cytek Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is $8.49 M
What is Cytek Biosciences quarterly EBITDA year-on-year change?
Over the past year, CTKB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$4.12 M (+399.22%)
What is Cytek Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of CTKB is -$649.00 K
What is the all time high TTM EBITDA for Cytek Biosciences?
Cytek Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is $20.16 M
What is Cytek Biosciences TTM EBITDA year-on-year change?
Over the past year, CTKB TTM earnings before interest, taxes, depreciation & amortization has changed by +$4.02 M (+86.11%)